Form D · Other
Cariina, Inc.
Boston, MA · CIK 0002024971
Offering snapshot reported Sep 2, 2025 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 2, 2025 | Initial | $2,999,998 | No comparison | 3 | SEC filing |
| Dec 26, 2024 | Initial | $2,577,469 | No comparison | 3 | SEC filing |
| May 29, 2024 | Initial | $3,521,519 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-556376
Source: Form D, filed Sep 2, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Barron | Director, Executive |
| Pedro De Almeida | Director |
| Miguel Galvez | Director |
| Jason Kranz | Director |
| Joseph Mirisola | Director |
Issuer details
Industry: Other (See others in industry)
Address:
40 Water Street Suite L 100
Boston, MA, 02109
Boston, MA, 02109